Evolutionary Insights in Nerve Bioprocessing: Harnessing Nature′s Blueprint for Nervous System Regeneration

Ciriza Hans^* and Neon Cysts
^*Correspondence: Ciriza Hans, Department of Pathophysiology, School of Medicine, Nantong University, Nantong, China, Email:

Keywords

Scaffolds • Nerve tissue engineering • Cells

Introduction

Tendon injuries are now a global health issue that affects millions of people each year, imposing a significant clinical burden on health-care systems that must bear the high costs associated with operations, rehabilitations, and infiltrations, among other things. Furthermore, the number of people who will suffer from this type of injury is expected to rise as life expectancy and the numbers of people who participate in sports continue to rise. Currently, the therapies used to treat this type of injury range from surgical to conservative to treatments involving the infiltration of cells or growth factors. However, these treatments are ineffective because reinjures are common.

Tissue engineering uses knowledge from engineering and life sciences to create structures that are similar to those found in the body, formed by the combination of different elements that, when used in the organism, allow for the recovery, maintenance, or improvement of various organs and tissues. To comprehend the techniques and elements used in tissue engineering applied to a specific organ or tissue, one must first comprehend the physiological nature of that organ or tissue. To put it another way, before studying tendon tissue engineering, it is necessary to understand what tendons are, what structure and composition they have, what tendon injuries are and how they occur, and the mechanisms that the organism itself has for tendon regeneration [1].

Furthermore, the understanding of the pathophysiology of tendon injuries and the inherent regenerative mechanisms of tendons are crucial in developing effective tissue engineering strategies for tendon repair. Tendons are dense connective tissues that connect muscles to bones, providing strength and transmitting forces during movement. They have a unique hierarchical structure composed of collagen fibers, proteoglycans, and other extracellular matrix components. Tendon injuries can occur due to trauma, overuse, or degenerative processes, leading to pain, limited mobility, and decreased quality of life.

Tissue engineering approaches for tendon repair aim to recreate the native tendon microenvironment to promote tissue regeneration. This involves the use of various elements, including cells, growth factors, scaffolds, and mechanical stimulation. Cells such as tenocytes, mesenchymal stem cells, and tendon progenitor cells are utilized to populate the scaffolds and enhance tendon regeneration. Growth factors, such as Transforming Growth Factor- Beta (TGF-β) and Platelet-Rich Plasma (PRP) are incorporated to promote cell proliferation, extracellular matrix synthesis, and angiogenesis. Scaffolds provide structural support and mimic the mechanical properties of native tendons, facilitating cell attachment, migration, and alignment.

Mechanical stimulation, through techniques like cyclic stretching or bioreactors, is employed to enhance tissue maturation and mechanical strength. Biophysical and biochemical cues play a vital role in guiding cellular behavior and tissue development. Tissue engineering holds immense potential in addressing the global health issue of tendon injuries. By understanding the physiology of tendons, the regenerative mechanisms, and combining elements of engineering and life sciences, innovative strategies can be developed to improve the outcomes of tendon repair, leading to reduced reinjury rates and enhanced patient recovery.

Literature Review

Nerve tissue engineering has emerged as a promising field with the potential to revolutionize the treatment of neural injuries and degenerative disorders. This literature review provides an overview of key studies and advancements in nerve tissue engineering, focusing on the utilization of cells, growth factors, scaffolds, and manufacturing processes to unleash the potential for neural regeneration.

Cells play a crucial role in nerve tissue engineering, and various cell sources have been investigated for their therapeutic potential. Neural Stem Cells (NSCs) have shown promise in promoting neural differentiation and regeneration. Studies have demonstrated the ability of NSCs to differentiate into specific neural lineages and integrate into host tissue, leading to functional recovery in animal models. Additionally, Schwann cells, which are vital for peripheral nerve regeneration, have been utilized to enhance axonal regeneration and myelination. Induced Pluripotent Stem Cells (iPSCs) offer an exciting avenue for personalized medicine, as they can be generated from patient-derived cells and differentiated into neural lineages for transplantation [1].

Growth factors play a critical role in promoting cell survival, axonal outgrowth, and tissue regeneration in nerve tissue engineering. Nerve Growth Factor (NGF), Brain-Derived Neurotrophic Factor (BDNF), and Glial Cell Line-Derived Neurotrophic Factor (GDNF) has been extensively studied for their neurotrophic properties. Delivery systems, such as sustained-release hydrogels or gene therapy approaches, have been employed to enhance the local and controlled release of growth factors, resulting in improved nerve regeneration outcomes.

Scaffolds provide structural support and guidance for cell growth and axonal regeneration. Biomaterials, including hydrogels, electrospun fibers, and 3D-printed scaffolds, have been engineered to mimic the native nerve microenvironment. These scaffolds can be designed to possess appropriate mechanical properties, bioactive cues, and topographical features to promote cell attachment, migration, and neurite extension. Integration of nanotechnology and biomaterials has further enabled the development of nerve conduits with enhanced biocompatibility and regenerative potential.

Manufacturing processes have been optimized to ensure reproducibility, scalability, and clinical translation of nerve tissue engineering therapies. Bioreactors, tissue printing, and microfabrication techniques allow for precise control over cellular organization, scaffold architecture, and stimulation parameters, ultimately influencing cell behavior and tissue maturation.

The integration of cells, growth factors, scaffolds, and manufacturing processes has unlocked new possibilities in nerve tissue engineering. The literature highlights the potential of neural stem cells, Schwann cells, and induced pluripotent stem cells in promoting neural regeneration. The controlled delivery of growth factors and the development of biomimetic scaffolds have shown promise in enhancing axonal outgrowth and tissue integration. Furthermore, advanced manufacturing techniques have facilitated the translation of nerve tissue engineering from the laboratory to clinical applications. Continued research and advancements in these areas hold the potential to revolutionize the treatment of nerve injuries and degenerative disorders, offering new hope for patients worldwide.

Discussion

Tendons have a low cellularity and are mostly made up of a waterrich extracellular matrix, according to biochemical analysis. In addition to water, the matrix contains various compounds such as proteoglycans and glycosaminoglycans, as well as elastin. Type I collagen accounts for roughly 80-90% of the overall collagen profile and is primarily responsible for tendon properties. Collagen I's basic unit is a heteropolymeric triple helix composed of two 1 chains and one 2 chain. Many minor collagen types, in addition to collagen I, play critical roles in proper tendon development and function. Type II and III collagen, for example, are present in much lower proportions in tendon tissues. Elastin is responsible for providing some of the tendon's characteristic flexibility.

Tendons have a hierarchical structure on the macroscopic level. They are constantly stretching and contracting, as previously stated, and are subjected to tensile forces of varying magnitudes. This type of movement is made possible by the tendons' oriented collagen fibres, their hierarchical organisation, the composition of their extracellular matrix, and the membranes or sheaths that cover the various structures. These last ones enable the fibres to glide along without causing friction. When it comes to the vascularisation of this tissue, the blood supply varies greatly between tendon types. Tendons are considered a poorly vascularized tissue in all cases. The vascularisation is mostly concentrated on the tendons' outer surface. Furthermore, the blood flow is extremely slow [2,3].

In terms of cell population, tendons contain several cell types with similar characteristics, the most abundant of which are tenocytes and tenoblast. Tenocytes are fibroblast cells that have an elongated shape and a stellate cross section. They are usually found in rows between the collagen fibrils. They synthesise ECM components and send signals to regulate tendon formation and development. Tenoblasts are another important cell type found in tendons. These are tendon immature cells. Tenoblasts are highly proliferative and motile. They are initially different in size and shape, but as the individual ages, the morphology of the cells changes and they become longer, more slender, and more uniform in shape, and transform into tenocytes [4].

Tendon recovery after injury is extremely poor due to tendon tissue's low cellularity, hypovascularity, and low metabolic activity. Furthermore, in the majority of patients, the healed tendon does not regain the mechanical properties of the original healthy tissue, and the rupture occurs again in a significant percentage of them. The problem of reinjury is caused by insufficient tissue regeneration, in which the molecular and histological structure of the newly formed tendon differs from the original. This situation may arise because the cells present in the regenerated tendon are not tenocytes, the composition or arrangement of the ECM is insufficient to meet the mechanical and physiological characteristics required by this tissue, or vascularization is much greater or less than required [5-7].

Conclusion

In conclusion many molecules with biological activity that perform various functions are secreted into the ECM during tendon regeneration. These molecules can also be used to treat tendon injuries by including them in scaffolds. Growth factors have been the most widely used and researched of these. Its functions are diverse, including increasing cell proliferation, enhancing ECM synthesis, and promoting angiogenesis or chemotaxis. The timing of their secretion and the role they play in tendon regeneration are becoming clearer. Many studies have been conducted to date that have incorporated some growth factors into scaffolds, most of which have been used to increase type I collagen synthesis or cell differentiation to tenocytes. However, it should be noted that an increasing number of organisations are proposing the approach of using more than one growth factor simultaneously. Controlling and adjusting the release of these growth factors at an appropriate time, as well as incorporating all the growth factors necessary to achieve a fullReferences recovery of the damaged tendon still seems difficult.

Acknowledgement

Not applicable.

Conflict of Interest

There are no conflicts of interest by authors.

References

1. Bakst, Richard L., Christine M. Glastonbury, Upendra Parvathaneni and Nora Katabi, et al. "Perineural invasion and perineural tumor spread in head and neck cancer.’’Int J Radiat Oncol 103 (2019): 1109-1124.

 Google Scholar, Crossref, Indexed at

2. Zhang, Ze, Ruoyan Liu, Rui Jin and Yanling Fan, et al. "Integrating clinical and genetic analysis of perineural invasion in head and neck squamous cell carcinoma." Front Oncol 9 (2019): 434.

Google Scholar, Crossref, Indexed at

3. Liebig, Catherine, Gustavo Ayala, Jonathan A. Wilks and David H. Berger, et al. "Perineural invasion in cancer: A review of the literature." Int J Cancer 115 (2009): 3379-3391.

 Google Scholar, Crossref, Indexed at

4. Chen, Wei, Shaozhong Dong, Jun Zhou and Moyi Sun, et al. "Investigation of myoepithelial cell differentiation into Schwann-like cells in salivary adenoid cystic carcinoma associated with perineural invasion." Mol Med Rep 6 (2012): 755-759.

Google Scholar, Crossref, Indexed at

5. Liu, Xiaohao, Xiaojun Yang, Chaoning Zhan and Yan Zhang, et al. "Perineural invasion in adenoid cystic carcinoma of the salivary glands: Where we are and where we need to go." Front Oncol 10 (2020): 1493.

Google Scholar, Crossref, Indexed at

6. Sung, Hyuna, Jacques Ferlay, Rebecca L. Siegel and Mathieu Laversanne, et al. "Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries." CA Cancer J Clin 71 (2021): 209-249.

Google Scholar, Crossref, Indexed at

7. Qureshi, Sohail A., Muhammed Umair Bashir and Ahmed Yaqinuddin. "Utility of DNA methylation markers for diagnosing cancer." Int J Surg 8 (2010): 194-198.

Google Scholar, Crossref, Indexed at